I listened to the Acadia Pharmaceuticals quarterly webcast today and have taken out the following observations.
1.Revenue up 64% from the corresponding quarter last year .
2.The margin on their drug sales are extremely good.
3.The company has an air of confident on what they are doing.
4.Updated sales guidance from a low of $220 million US($305 aussie)and high of $225US($312 aussie).
5.Cash at bank at end of year between $160 and $170mill US.
It will be interesting to see what the market in the US thinks about the update tonite.My guess is that they will do a capital raise very soon based on the above as the window for a cap raise closes up towards the end of the year.
Acadia Pharmaceuticals quarterly
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.34 |
Change
0.320(1.68%) |
Mkt cap ! $2.469B | |||
| Open | High | Low | Value | Volume |
| $19.20 | $19.41 | $18.55 | $13.89M | 728.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 624 | $19.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.35 | 6719 | 2 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.40 |
Change
0.320 ( 1.70 %) |
||||
| Open | High | Low | Volume | ||
| $19.12 | $19.40 | $18.55 | 139309 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| NEU (ASX) Chart |